Letters to the Editor Hypovolemia-induced obesity and diabetes To the Editor: The article by Saiki and colleagues [1] published in the Metabolism entitled “Circulating angiotensin II is asso- ciated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus” is very interesting in that it points out clearly the association between circulating angiotensin levels and the pathophy- siology of obesity and diabetes. At first glance, this is rather unusual, as why would a hormone intimately implicated in cardiovascular and water balance functions be involved with fat accumulation and insulin resistance. However, these “unusual” associations have given rise to a series of reports, all independent at the time, which now taken together make sense [2-4]. It would appear that the common feature in the origin not only of hypertension but also of obesity and diabetes is hypovolemia. This is a physiologic state that comes about through reduced fluid intake and has as primary signal the release of renin that generates angiotensin II in the blood. Interestingly, neurochemical changes characteristic of extracellular dehydration have been found in the brain of obese Zucker rats, a model of obesity and type 2 diabetes [5]. Moreover, in animal studies on obesity, inhibition of the renin- angiotensin system produces an increased fluid intake that has been suggested to lead to lipolysis and subsequent weight loss [3]. In other studies, it has been noted that inhibition of the renin-angiotensin system allows cells to restore membrane glucose transport and to increase insulin sensitivity [4]. It was thus proposed that this would restore to normal cellular carbohydrate and fat metabolism [4]. However, insulin signaling is linked also to cell volume regulation [6]; and cell volume regulation would be dependent on body hydration state. We thus come back to the regulation of hypovolemia. It is thus not surprising to find that circulating angiotensin levels are elevated in conditions of obese subjects with type 2 diabetes mellitus [1], and it would be interesting to propose that increased water intake be encouraged along with renin-angiotensin system blockade in cases of obesity and diabetes. Serguei O. Fetissov Digestive System and Nutrition Laboratory (ADEN EA3234) Institute of Biomedical Research Rouen University IFR23, Rouen, France Simon N. Thornton INSERM, U684 Vandoeuvre les Nancy, France Université Henri Poincaré Nancy Université, Nancy, France E-mail address: Simon.Thornton@scbiol.uhp-nancy.fr doi:10.1016/j.metabol.2009.06.022 References [1] Saiki A, Ohira M, Endo K, et al. Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism 2009;58:708-13. [2] Thornton SN. Angiotensin, the hypovolaemia hormone, aggravates hypertension, obesity, diabetes and cancer. J Intern Med 2009;265: 616-7. [3] Thornton SN, Even PC, van Dijk G. Hydration increases cell metabolism. Int J Obes (Lond) 2009;33:385. [4] Thornton SN. Angiotensin-induced metabolic dysfunction. J Hypertens 2009;27:658-9. [5] Fetissov S, Nicolaidis S. Neuropeptide Y in the magnocellular hypothalamic neurons of obese Zucker rats. Neuropeptides 1998;32: 63-6. [6] Schliess F, Häussinger D. Cell volume and insulin signaling. Int Rev Cytol 2003;225:187-228. Available online at www.sciencedirect.com Metabolism Clinical and Experimental 58 (2009) 1678–1679 www.metabolismjournal.com 0026-0495/$ – see front matter © 2009 Elsevier Inc. All rights reserved.